Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy.

Abstract:

:A diverse group of proteins, the activities of which are precisely orchestrated during mitosis, have emerged as targets for cancer therapeutics; these include the Aurora kinases (AKs), Polo-like kinases (PLKs), and the kinesin spindle protein (KSP). KSP is essential for the proper separation of spindle poles during mitosis. Agents that target KSP selectively act on cells undergoing cell division, which means that KSP inhibitors are mitosis-specific drugs, and have demonstrated remarkable activities in vitro. However, a significant obstacle to the success of KSP inhibitors is that these compounds, with tremendous efficacy in vitro, have demonstrated little or even no antitumor activity in vivo. Accumulated data suggest that a combination of KSP inhibitors with various cytostatic drugs will result in a more powerful tumor-killing effect than monotherapy. Combination therapies might predominate and represent the next frontier in the discovery research of KSP inhibitors as potential anticancer drugs. Few published studies have reviewed combination therapy using KSP inhibitors. Herein we provide a comprehensive review of the literature on KSP inhibitor monotherapy and therapeutic combinations. The current state and problems are also discussed.

journal_name

ChemMedChem

journal_title

ChemMedChem

authors

Song H,Zhou S,Wang R,Li S

doi

10.1002/cmdc.201300228

subject

Has Abstract

pub_date

2013-11-01 00:00:00

pages

1736-49

issue

11

eissn

1860-7179

issn

1860-7187

journal_volume

8

pub_type

杂志文章,评审
  • Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance.

    abstract::The emergence and dissemination of multidrug resistant (MDR) pathogens resistant to nearly all available antibiotics poses a significant threat in clinical therapy. Among them, Klebsiella pneumoniae clinical isolates overexpressing KPC-2 carbapenemase are the most worrisome, extending bacterial resistance to last-reso...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700788

    authors: Celenza G,Vicario M,Bellio P,Linciano P,Perilli M,Oliver A,Blazquez J,Cendron L,Tondi D

    更新日期:2018-04-06 00:00:00

  • Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.

    abstract::Based on the crystal structures of human alpha-GalCer-CD1d and iNKT-alpha-GalCer-CD1d complexes, nonglycosidic analogues of alpha-GalCer were synthesized. They activate iNKT cells resulting in dendritic cell maturation and the priming of antigen-specific T and B cells. Therefore, they are attractive adjuvants in vacci...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800354

    authors: Reddy BG,Silk JD,Salio M,Balamurugan R,Shepherd D,Ritter G,Cerundolo V,Schmidt RR

    更新日期:2009-02-01 00:00:00

  • Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.

    abstract::Selective inhibitors of the protein tyrosine phosphatase SHP2 (src homology region 2 domain phosphatase; PTPN11), an enzyme that is deregulated in numerous human tumors, were generated through a combination of chemical synthesis and structure-based rational design. Seventy pyridazolon-4-ylidenehydrazinyl benzenesulfon...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500015

    authors: Grosskopf S,Eckert C,Arkona C,Radetzki S,Böhm K,Heinemann U,Wolber G,von Kries JP,Birchmeier W,Rademann J

    更新日期:2015-05-01 00:00:00

  • Synthesis of imidazothiazole-chalcone derivatives as anticancer and apoptosis inducing agents.

    abstract::A new class of imidazo[2,1-b]thiazole chalcone derivatives were synthesized and evaluated for their anticancer activity. These chalcone derivatives show promising activity, with log GI(50) values ranging from -7.51 to -4.00. The detailed biological aspects of these derivatives toward the MCF-7 cell line were studied. ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201000346

    authors: Kamal A,Dastagiri D,Ramaiah MJ,Reddy JS,Bharathi EV,Srinivas C,Pushpavalli SN,Pal D,Pal-Bhadra M

    更新日期:2010-11-08 00:00:00

  • Identification of the binding site of an allosteric ligand using STD-NMR, docking, and CORCEMA-ST calculations.

    abstract::Singling out the truth: A combined application of STD-NMR, molecular docking, and CORCEMA-ST calculations is described as an attractive, easily applicable tool for the identification and validation of the binding site for allosteric ligands, with potential application as an aid in drug discovery research. ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300267

    authors: Zhang W,Li R,Shin R,Wang Y,Padmalayam I,Zhai L,Krishna NR

    更新日期:2013-10-01 00:00:00

  • 18 F-Labeled Derivatives of Irbesartan for Angiotensin II Receptor PET Imaging.

    abstract::The renin angiotensin aldosterone system (RAAS) is a hormonal cascade involved in the regulation of blood pressure and electrolyte balance, and represents a common target for the treatment of various diseases including hypertension, heart failure, and diabetes. Herein we present a novel 18 F-labeled derivative of the ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800638

    authors: Hoffmann M,Chen X,Hirano M,Arimitsu K,Kimura H,Higuchi T,Decker M

    更新日期:2018-12-06 00:00:00

  • Detection of overexpressed COX-2 in precancerous lesions of hamster pancreas and lungs by molecular imaging: implications for early diagnosis and prevention.

    abstract::The enzyme cyclooxygenase-2 (COX-2) is overexpressed in many cancers, cardiovascular disease, neurodegenerative disorders, and arthritis. Selective inhibitors of COX-2 have been developed as therapeutics or preventive agents for these diseases. However, recent reports have revealed a significant increase in cardiovasc...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200500032

    authors: Schuller HM,Kabalka G,Smith G,Mereddy A,Akula M,Cekanova M

    更新日期:2006-06-01 00:00:00

  • Mixed-model QSAR at the glucocorticoid receptor: predicting the binding mode and affinity of psychotropic drugs.

    abstract::The glucocorticoid receptor (GR) is a member of the nuclear receptor superfamily that affects immune response, development, and metabolism in target tissues. Glucocorticoids are widely used to treat diverse pathophysiological conditions, but their clinical applicability is limited by side effects. A prediction of the ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800274

    authors: Spreafico M,Ernst B,Lill MA,Smiesko M,Vedani A

    更新日期:2009-01-01 00:00:00

  • Differentiating Antiproliferative and Chemopreventive Modes of Activity for Electron-Deficient Aryl Isothiocyanates against Human MCF-7 Cells.

    abstract::The consumption of Brassica vegetables provides beneficial effects through organic isothiocyanates (ITCs), products of the enzymatic hydrolysis of glucosinolate secondary metabolites. The ITC l-sulforaphane (l-SFN) is the principle agent in broccoli that demonstrates several modes of anticancer action. While the antic...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800348

    authors: Anderson RH,Lensing CJ,Forred BJ,Amolins MW,Aegerter CL,Vitiello PF,Mays JR

    更新日期:2018-08-20 00:00:00

  • Screening for the drug-phospholipid interaction: correlation to phospholipidosis.

    abstract::Phospholipid bilayers represent a complex, anisotropic environment fundamentally different from bulk oil or octanol, for instance. Even "simple" drug association to phospholipid bilayers can only be fully understood if the slab-of-hydrocarbon approach is abandoned and the complex, anisotropic properties of lipid bilay...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.200900052

    authors: Alakoskela JM,Vitovic P,Kinnunen PK

    更新日期:2009-08-01 00:00:00

  • Synthesis and cell growth inhibitory activity of six non-glycosaminoglycan-type heparin-analogue trisaccharides.

    abstract::The design and synthesis of heparin mimetics with high anticancer activity but no anticoagulant activity is an important task in medicinal chemistry. Here, we present the efficient synthesis of five Glc-GlcA-Glc sequenced and one Glc-IdoA-Glc sequenced non-glycosaminoglycan, heparin-related trisaccharides with various...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000917

    authors: Lisztes E,Mező E,Demeter F,Horváth L,Bősze S,Tóth BI,Borbás A,Herczeg M

    更新日期:2021-01-12 00:00:00

  • G-quadruplex recognition by quinacridines: a SAR, NMR, and biological study.

    abstract::The synthesis of a novel group of quinacridine-based ligands (MMQs) is described along with an evaluation of their G-quadruplex binding properties. A set of biophysical assays was applied to characterize their interaction with DNA quadruplexes: FRET-melting experiments and equilibrium microdialysis were used to evalua...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600286

    authors: Hounsou C,Guittat L,Monchaud D,Jourdan M,Saettel N,Mergny JL,Teulade-Fichou MP

    更新日期:2007-05-01 00:00:00

  • Light-Switchable Antagonists for the Histamine H1 Receptor at the Isolated Guinea Pig Ileum.

    abstract::The histamine H1 G protein-coupled receptor (GPCR) plays an important role in allergy and inflammation. Existing drugs that address the H1 receptor differ in their chemical structure, pharmacology, and side effects. Light-controllable spatial and temporal activity regulation of photochromic H1 ligands may contribute t...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800815

    authors: Rustler K,Pockes S,König B

    更新日期:2019-03-22 00:00:00

  • Sulfide Analogues of Flupirtine and Retigabine with Nanomolar KV 7.2/KV 7.3 Channel Opening Activity.

    abstract::The potassium channel openers flupirtine and retigabine have proven to be valuable analgesics or antiepileptics. Their recent withdrawal due to occasional hepatotoxicity and tissue discoloration, respectively, leaves a therapeutic niche unfilled. Metabolic oxidation of both drugs gives rise to the formation of electro...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900112

    authors: Bock C,Surur AS,Beirow K,Kindermann MK,Schulig L,Bodtke A,Bednarski PJ,Link A

    更新日期:2019-05-06 00:00:00

  • Cytotoxic rhodium(III) and iridium(III) polypyridyl complexes: structure-activity relationships, antileukemic activity, and apoptosis induction.

    abstract::Meridional rhodium(III) polypyridyl complexes of the type mer-[RhX(3)(DMSO)(pp)] (X=Cl, pp=phen 1, dpq 2, dppz 3; X=Br, pp=phen 4) represent a promising class of potent cytostatic agents for the treatment of lymphoma and leukemia. Exposure of their DMSO solutions to light leads to slow isomerization to mixtures of the...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800311

    authors: Dobroschke M,Geldmacher Y,Ott I,Harlos M,Kater L,Wagner L,Gust R,Sheldrick WS,Prokop A

    更新日期:2009-02-01 00:00:00

  • Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanism.

    abstract::The Cdc25 dual specificity phosphatases have central roles in coordinating cellular signalling processes and cell proliferation. It has been reported that an improper amplification or activation of these enzymes is a distinctive feature of a number of human cancers, including breast cancers. Thus, the inhibition of Cd...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200500092

    authors: Lavecchia A,Cosconati S,Limongelli V,Novellino E

    更新日期:2006-05-01 00:00:00

  • A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus.

    abstract::Over the years, the 2-substituted imidazoline nucleus has been demonstrated to be a bioversatile structural motif. In this study, novel imidazoline derivatives bearing a 3- and/or 4-hydroxy- or methoxy-substituted phenyl ring, linked by an ethylene bridge to position 2 of an N-benzyl- or N-phenethyl-substituted imidaz...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600022

    authors: Mammoli V,Bonifazi A,Dal Ben D,Giannella M,Giorgioni G,Piergentili A,Pigini M,Quaglia W,Thomas A,Newman AH,Ferré S,Sanchez-Soto M,Keck TM,Del Bello F

    更新日期:2016-08-19 00:00:00

  • Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy.

    abstract::Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) is a small molecule with potent anticancer activity. Like other 1,4-naphthoquinones, it exhibits electrophilic reactivity towards biological nucleophiles. We demonstrate that plumbagin and structurally related 1,4-naphthoquinones with at least one unsubstituted quinoid...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000157

    authors: Chrastina A,Welsh J,Rondeau G,Abedinpour P,Borgström P,Baron VT

    更新日期:2020-07-20 00:00:00

  • A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

    abstract::Into the fold: Prion diseases are neurodegenerative disorders characterized by the accumulation in the brain of a self-replicating, misfolded isoform (PrPSc ) of the cellular prion protein (PrPC ). No therapies are available for these pathologies. We capitalized on previously described cell-based assays to screen a li...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700302

    authors: Massignan T,Sangiovanni V,Biggi S,Stincardini C,Elezgarai SR,Maietta G,Andreev IA,Ratmanova NK,Belov DS,Lukyanenko ER,Belov GM,Barreca ML,Altieri A,Kurkin AV,Biasini E

    更新日期:2017-08-22 00:00:00

  • Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.

    abstract::Iridium(III) complexes of the type [Ir(η(5) -C5 Me5 )Cl2 {Ph2 PCH2 CH2 CH2 S(O)x Ph-κP}] (x=0-2; 1-3) and [Ir(η(5) -C5 Me5 )Cl{Ph2 PCH2 CH2 CH2 S(O)x Ph-κP,κS}][PF6 ] (x=0-1; 4 and 5) with 3-(diphenylphosphino)propyl phenyl sulfide, sulfoxide, and sulfone ligands Ph2 PCH2 CH2 CH2 S(O)x Ph were designed, synthesized, a...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300479

    authors: Ludwig G,Ranđelović I,Maksimović-Ivanić D,Mijatović S,Bulatović MZ,Miljković D,Korb M,Lang H,Steinborn D,Kaluđerović GN

    更新日期:2014-07-01 00:00:00

  • Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.

    abstract::Targeting protein-protein interactions, such as the HIV-1 gp120-CD4 interface, has become a cutting-edge approach in the current drug discovery scenario. Many small molecules have been developed so far as inhibitors of the interaction between CD4 and HIV-1 gp120. However, due to a variety of reasons such as solubility...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200584

    authors: Tintori C,Selvaraj M,Badia R,Clotet B,Esté JA,Botta M

    更新日期:2013-03-01 00:00:00

  • Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.

    abstract::Clostridium difficile infection (CDI) symptoms range from diarrhea to severe toxic megacolon and even death. Due to its rapid acquisition of resistance, C. difficile is listed as an urgent antibiotic-resistant threat, and has surpassed methicillin-resistant Staphylococcus aureus (MRSA) as the most common hospital-acqu...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800240

    authors: Li C,Teng P,Peng Z,Sang P,Sun X,Cai J

    更新日期:2018-07-18 00:00:00

  • Recent advances in the discovery of N-myristoyltransferase inhibitors.

    abstract::N-Myristoyltransferase (NMT) is a cytosolic monomeric enzyme present in eukaryotes such as fungi and protozoa, but is not found in prokaryotes. The attachment of a 14-carbon saturated fatty acid, myristate, from myristoyl-CoA (14:0 CoA) to the N-terminal glycine residue in a specific set of cellular proteins is common...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402174

    authors: Zhao C,Ma S

    更新日期:2014-11-01 00:00:00

  • Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia.

    abstract::Small-molecule inhibitors of hypoxia-inducible factor prolyl hydroxylases (HIF-PHs) are currently under clinical development as novel treatment options for chronic kidney disease (CKD) associated anemia. Inhibition of HIF-PH mimics hypoxia and leads to increased erythropoietin (EPO) expression and subsequently increas...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700783

    authors: Beck H,Jeske M,Thede K,Stoll F,Flamme I,Akbaba M,Ergüden JK,Karig G,Keldenich J,Oehme F,Militzer HC,Hartung IV,Thuss U

    更新日期:2018-05-23 00:00:00

  • Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.

    abstract::A series of four stable synthetic bacteriochlorins was tested in vitro in HeLa cells for their potential in photodynamic therapy (PDT). The parent bacteriochlorin (BC), dicyano derivative (NC)(2)BC and corresponding zinc chelate (NC)(2)BC-Zn and palladium chelate (NC)(2)BC-Pd were studied. Direct dilution of a solutio...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200351

    authors: Huang YY,Balasubramanian T,Yang E,Luo D,Diers JR,Bocian DF,Lindsey JS,Holten D,Hamblin MR

    更新日期:2012-12-01 00:00:00

  • A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.

    abstract::Protein tyrosine phosphatase 1B (PTP1B) is an important target for the treatment of diabetes. A series of thiazolidin-4-one derivatives 8-22 was designed, synthesized and investigated as PTP1B inhibitors. The new molecules inhibited PTP1B with IC50 values in the micromolar range. 5-(Furan-2-ylmethylene)-2-(4-nitrophen...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000055

    authors: Patel AD,Pasha TY,Lunagariya P,Shah U,Bhambharoliya T,Tripathi RKP

    更新日期:2020-07-03 00:00:00

  • Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys-Covalent Antagonists of Protein-Protein Interactions.

    abstract::Recently we reported on aryl-fluorosulfates as possible stable and effective electrophiles for the design of lysine covalent, cell permeable antagonists of protein-protein interactions (PPIs). Here we revisit the use of aryl-sulfonyl fluorides as Lys-targeting moieties, incorporating these electrophiles in XIAP (X-lin...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000355

    authors: Gambini L,Udompholkul P,Salem AF,Baggio C,Pellecchia M

    更新日期:2020-11-18 00:00:00

  • Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues.

    abstract::The polyether ionophore salinomycin (SAL) has captured much interest because of its potent activity against cancer cells and cancer stem cells. Our previous studies have indicated that C1/C20 double-modification of SAL is a useful strategy to generate diverse agents with promising biological activity profiles. Thus, h...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900593

    authors: Czerwonka D,Urbaniak A,Sobczak S,Piña-Oviedo S,Chambers TC,Antoszczak M,Huczyński A

    更新日期:2020-01-17 00:00:00

  • Discovery of N-arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide derivatives as HCV NS5B polymerase inhibitors.

    abstract::The metal ion chelating β-N-hydroxy-γ-ketocarboxamide pharmacophore was integrated into a quinazolinone scaffold, leading to N-arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide derivatives as hepatitis C virus (HCV) NS5B polymerase inhibitors. Lead optimization led to the identification of N-phenylpropyl c...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200058

    authors: Deore RR,Chen GS,Chang PT,Chern TR,Lai SY,Chuang MH,Lin JH,Kung FL,Chen CS,Chiou CT,Chern JW

    更新日期:2012-05-01 00:00:00

  • Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluation.

    abstract::Targeting LRH-1: Virtual screening and molecular modeling were used to identify novel antagonists of liver receptor homolog-1 (LRH-1), an emerging therapeutic target for breast cancer. Hit compounds were synthesized and biologically assayed, and the preliminary results suggest that raloxifene-based analogues, substitu...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200307

    authors: Rey J,Hu H,Kyle F,Lai CF,Buluwela L,Coombes RC,Ortlund EA,Ali S,Snyder JP,Barrett AG

    更新日期:2012-11-01 00:00:00